Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Generic Yohimbine vs Yocon-Glenwood
NCT00975325Phase 4Completed
- Sponsor
- Walter Ritter GmbH + Co. KG
- Start
- Oct 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of yohimbine in erectile dysfunction (ED) (2 arms), sponsored by Walter Ritter GmbH + Co. KG. Primary endpoints: Area Under the Concentration-Time Curve (AUC0-tlast) at Day 1 and Maximum Plasma Concentration at Day 1. Started Oct 2009; status: completed.
02
Drugs
yohimbine
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00975325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00975325.